Published: 28 November 2022
Author(s): Steven Deitelzweig, Allison Keshishian, Amiee Kang, Aaron Jenkins, Nipun Atreja, Patricia Schuler, Jenny Jiang, Huseyin Yuce, Xiaoxi Sun, Gregory Y.H. Lip
Section: Original article

Atrial fibrillation (AF) is the most common cardiac arrhythmia in the United States, with prevalence currently estimated at 6 million which is projected to increase to 12 million by 2030, in line with the aging population [1,2]. AF is associated with a 5-fold increased risk of stroke [3], a 3 to 11-fold risk of heart failure (for men and women, respectively) [4], and a higher risk of premature mortality and increasing healthcare costs [5].


Stay informed on our latest news!


This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.